Share
6,851 Posts.
lightbulb Created with Sketch. 2536
clock Created with Sketch.
26/06/18
11:43
Share
Originally posted by RBx
↑
Harvett,
Once again you have missed the point.
You accuse Graham Kelly of having improbable timelines, but you (wilfully?) ignore the fact that his timelines were based on starting clinical trials in Australia, where an IND is not required.
The new regime at Kazia went another route, which is their prerogative. The mistake they made, in my opinion, was that in their zeal to not do a Kelly, they stopped communicating with shareholders.
Expand
Now you're just getting embarrassing....memory starting to get a bit fuzzy is it....
#Novogen/#CanTx: Appoint #Regis Technologies, #Pharmaceutics International to produce anti-cancer drug Cantrixil ahead of IND app early 2015
JUL 25 2014 - 10:48 AM
#Novogen/#CanTx: Appoint #Regis Technologies, #Pharmaceutics International to produce anti-cancer drug Cantrixil ahead of IND app early 2015